Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 19.15 is 37% above its 5-year average of 13.93, around the middle of its 5-year range (3.49–31.15).
As of the fiscal period ended Tuesday, June 30, 2026. 17.99% above its 12-month average of 16.23.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.15.
QUICK RATIO (ACID-TEST)
19.15
QUICK RATIO (ACID-TEST) AVG TTM
16.23
QUICK RATIO (ACID-TEST) AVG 3Y
9.46
QUICK RATIO (ACID-TEST) AVG 5Y
13.93
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.99%
CURRENT VS 3Y AVG
+102.39%
CURRENT VS 5Y AVG
+37.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+471.54%
vs the sector median at left
Vor Biopharma Inc.
Market Cap
$992.14M
Quick Ratio (Acid-Test)
19.15
TTM Avg
16.23
3Y Avg
9.46
5Y Avg
13.93
Market Cap
$996.65M
Quick Ratio (Acid-Test)
5.35
TTM Avg
6.89
3Y Avg
6.87
5Y Avg
8.97
Market Cap
$998.69M
Quick Ratio (Acid-Test)
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$982.46M
Quick Ratio (Acid-Test)
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$981.66M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.39
3Y Avg
1.76
5Y Avg
2.46
Market Cap
$978.09M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$973.93M
Quick Ratio (Acid-Test)
3.94
TTM Avg
2.64
3Y Avg
3.04
5Y Avg
2.66
Market Cap
$1.02B
Quick Ratio (Acid-Test)
5.85
TTM Avg
6.12
3Y Avg
6.56
5Y Avg
10.14
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vor Biopharma Inc. (VOR) | $992.14M | 19.15 | 16.23 | 9.46 | 13.93 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | 5.35 | 6.89 | 6.87 | 8.97 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | 8.42 | 11.89 | 15.48 | 17.00 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | 15.08 | 22.50 | 27.08 | 27.08 |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | 3.76 | 1.39 | 1.76 | 2.46 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 3.94 | 2.64 | 3.04 | 2.66 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | 5.85 | 6.12 | 6.56 | 10.14 |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | 16.35 | 49.13 | 36.31 | 29.96 |
Quick Ratio
19.15
Excludes inventory
Current Ratio
19.15
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 19.15 |
| 2026-03-31 | 31.15 |
| 2025-12-31 | 18.20 |
| 2025-09-30 | 9.16 |
| 2025-06-30 | 3.49 |
| 2025-03-31 | 3.88 |
| 2024-12-31 | 5.19 |
| 2024-09-30 | 4.69 |
| 2024-06-30 | 6.54 |
| 2024-03-31 | 8.46 |
| 2023-12-31 | 9.04 |
| 2023-09-30 | 10.69 |
| 2023-06-30 | 15.05 |
| 2023-03-31 | 17.24 |
| 2022-12-31 | 18.06 |
| 2022-09-30 | 12.86 |
| 2022-06-30 | 12.95 |
| 2022-03-31 | 10.49 |
| 2021-12-31 | 21.12 |
| 2021-09-30 | 25.20 |
| 2021-06-30 | 30.02 |
| 2021-03-31 | 30.85 |
| 2020-12-31 | 4.81 |
| 2020-09-30 | 8.62 |
| 2020-06-30 | 18.96 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 3.45 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
